Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study Clinical trials frequently ...

Canine lymphoma is the most commonly diagnosed cancer in dogs. This is why November 7th has been designated as National Canine Lymphoma Awareness Day. This day was created in 2015 by Terry Simmons, a ...

Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...

Dr. Brittany Kleszynski is a licensed veterinarian and freelance medical writer who specializes in creating meaningful content that engages readers and speaks directly to the intended audiences. She ...

A treatment combination that includes Velcade and Rituxan helps improve responses and the safety profile in marginal zone lymphoma, according to a phase 2 trial. Velcade (bortezomib), Rituxan ...